Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Inspire discontinuedSensory organs
Neurocrine Biosciences accomplished Phase IINervous system
Abbott Laboratories in Phase IIAntineoplastic & immunomodulating agents
Angstrom in Phase IIAntineoplastic & immunomodulating agents
Rigel Pharmaceuticals No drug name Phase II completedMusculoskeletal system
Arena in Phase IIIAlimentary tract & metabolism
Infinity No drug name in Phase IIAntineoplastic & immunomodulating agents
Newron accomplished Phase IINervous system
NPS in Phase IINervous system
ZymoGenetics No drug name accomplished Phase I, Phase II initiatedAntineoplastic & immunomodulating agents
Array BioPharma No drug name Phase II completedAntineoplastic & immunomodulating agents
Immtech International in Phase IIAntiparasitic products
Genzyme in Phase IIBlood & blood forming organs
Anadys accomplished Phase IIAntineoplastic & immunomodulating agents
Alexion discontinuedCardiovascular system
Abbott Laboratories Submitted for approval in USASystemic hormonal preparations
Abbott Laboratories in Phase IIDermatologicals
Abbott Laboratories in Phase IIIGenito urinary system & sex hormones
Inspire accomplished Phase IIISensory organs
Dainippon Sumimoto Pharma accomplished Phase IIINervous system

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.